English version of guidelines for the management of asteatosis 2021 in Japan
This is the English version of guidelines for the management of asteatosis 2021 in Japan. Asteatosis is a synonym of xerosis found in a wide range of diseases that induce dry skin through impaired functions of either water retention of the stratum corneum or skin covering with acid mantle. Patients...
Gespeichert in:
| Veröffentlicht in: | Journal of dermatology 2022-03, Vol.49 (3), p.e77-e90 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e90 |
|---|---|
| container_issue | 3 |
| container_start_page | e77 |
| container_title | Journal of dermatology |
| container_volume | 49 |
| creator | Saeki, Hidehisa Tsunemi, Yuichiro Arai, Satoru Ichiyama, Susumu Katoh, Norito Kikuchi, Katsuko Kubo, Akiharu Terui, Tadashi Nakahara, Takeshi Futamura, Masaki Murota, Hiroyuki Igarashi, Atsuyuki |
| description | This is the English version of guidelines for the management of asteatosis 2021 in Japan. Asteatosis is a synonym of xerosis found in a wide range of diseases that induce dry skin through impaired functions of either water retention of the stratum corneum or skin covering with acid mantle. Patients with asteatosis may be accompanied by pruritus. Moisturizers are the first‐line treatment for asteatosis and their adequate use must be recommended. The main purpose of the present guidelines is to define skin symptoms requiring treatment with moisturizers for medical use in patients with asteatosis. If the deterioration of marked scaling or scratch marks is predicted, therapeutic intervention with moisturizers for medical use should be considered even in the absence of pruritus. Regarding six important points requiring decision‐making in clinical practice (clinical questions), we evaluated the balance between the benefits and harm of medical interventions in reference to previous reports of clinical research, and presented the recommendation grades and evidence levels to optimize the patient outcome by medical interventions. |
| doi_str_mv | 10.1111/1346-8138.16293 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2615918324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2615918324</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4153-e81147172d0eed217a066c5e373c74940c8eb40430285e4cc18d67f6ecfb2c6f3</originalsourceid><addsrcrecordid>eNqFkLtOwzAUQC0EouUxsyFLLCwpfsV2RlTKo6rEArPlOjfFVeKUOAH170kodGDBy5Wsc4-uDkIXlExo_24oFzLRlOsJlSzjB2i8_zlEY8J1mjBB1AidxLgmhGUpJcdoxEWmiFJyjBazsCp9fMMf0ERfB1wXeNX5HEofIOKibnD7Briywa6ggtAOgI0t2LaOPmJGGMU-4Lnd2HCGjgpbRjj_mafo9X72Mn1MFs8PT9PbReIETXkCmlKhqGI5AcgZVZZI6VLgijslMkGchqUgghOmUxDOUZ1LVUhwxZI5WfBTdL3zbpr6vYPYmspHB2VpA9RdNEzSNKOaM9GjV3_Qdd01ob-up_pUmqiU9NTNjnJNHWMDhdk0vrLN1lBihtBmyGqGrOY7dL9x-ePtlhXke_63bA-kO-DTl7D9z2fmd7Od-AtaE4T7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2634680750</pqid></control><display><type>article</type><title>English version of guidelines for the management of asteatosis 2021 in Japan</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Saeki, Hidehisa ; Tsunemi, Yuichiro ; Arai, Satoru ; Ichiyama, Susumu ; Katoh, Norito ; Kikuchi, Katsuko ; Kubo, Akiharu ; Terui, Tadashi ; Nakahara, Takeshi ; Futamura, Masaki ; Murota, Hiroyuki ; Igarashi, Atsuyuki</creator><creatorcontrib>Saeki, Hidehisa ; Tsunemi, Yuichiro ; Arai, Satoru ; Ichiyama, Susumu ; Katoh, Norito ; Kikuchi, Katsuko ; Kubo, Akiharu ; Terui, Tadashi ; Nakahara, Takeshi ; Futamura, Masaki ; Murota, Hiroyuki ; Igarashi, Atsuyuki</creatorcontrib><description>This is the English version of guidelines for the management of asteatosis 2021 in Japan. Asteatosis is a synonym of xerosis found in a wide range of diseases that induce dry skin through impaired functions of either water retention of the stratum corneum or skin covering with acid mantle. Patients with asteatosis may be accompanied by pruritus. Moisturizers are the first‐line treatment for asteatosis and their adequate use must be recommended. The main purpose of the present guidelines is to define skin symptoms requiring treatment with moisturizers for medical use in patients with asteatosis. If the deterioration of marked scaling or scratch marks is predicted, therapeutic intervention with moisturizers for medical use should be considered even in the absence of pruritus. Regarding six important points requiring decision‐making in clinical practice (clinical questions), we evaluated the balance between the benefits and harm of medical interventions in reference to previous reports of clinical research, and presented the recommendation grades and evidence levels to optimize the patient outcome by medical interventions.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16293</identifier><identifier>PMID: 34970776</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>asteatosis ; clinical questions ; Decision making ; Emollients - therapeutic use ; guidelines ; Humans ; Ichthyosis ; Japan ; Medical treatment ; moisturizers for medical use ; Patients ; Pruritus ; Pruritus - diagnosis ; Pruritus - drug therapy ; Pruritus - etiology ; Skin ; Stratum corneum ; xerosis</subject><ispartof>Journal of dermatology, 2022-03, Vol.49 (3), p.e77-e90</ispartof><rights>2021 Japanese Dermatological Association</rights><rights>2021 Japanese Dermatological Association.</rights><rights>Copyright © 2022 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4153-e81147172d0eed217a066c5e373c74940c8eb40430285e4cc18d67f6ecfb2c6f3</cites><orcidid>0000-0003-1508-9514 ; 0000-0002-3498-2482 ; 0000-0002-5903-3187 ; 0000-0003-2811-8273 ; 0000-0002-1095-0355 ; 0000-0002-0450-1377 ; 0000-0003-3590-6489</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.16293$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.16293$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34970776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saeki, Hidehisa</creatorcontrib><creatorcontrib>Tsunemi, Yuichiro</creatorcontrib><creatorcontrib>Arai, Satoru</creatorcontrib><creatorcontrib>Ichiyama, Susumu</creatorcontrib><creatorcontrib>Katoh, Norito</creatorcontrib><creatorcontrib>Kikuchi, Katsuko</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Terui, Tadashi</creatorcontrib><creatorcontrib>Nakahara, Takeshi</creatorcontrib><creatorcontrib>Futamura, Masaki</creatorcontrib><creatorcontrib>Murota, Hiroyuki</creatorcontrib><creatorcontrib>Igarashi, Atsuyuki</creatorcontrib><title>English version of guidelines for the management of asteatosis 2021 in Japan</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>This is the English version of guidelines for the management of asteatosis 2021 in Japan. Asteatosis is a synonym of xerosis found in a wide range of diseases that induce dry skin through impaired functions of either water retention of the stratum corneum or skin covering with acid mantle. Patients with asteatosis may be accompanied by pruritus. Moisturizers are the first‐line treatment for asteatosis and their adequate use must be recommended. The main purpose of the present guidelines is to define skin symptoms requiring treatment with moisturizers for medical use in patients with asteatosis. If the deterioration of marked scaling or scratch marks is predicted, therapeutic intervention with moisturizers for medical use should be considered even in the absence of pruritus. Regarding six important points requiring decision‐making in clinical practice (clinical questions), we evaluated the balance between the benefits and harm of medical interventions in reference to previous reports of clinical research, and presented the recommendation grades and evidence levels to optimize the patient outcome by medical interventions.</description><subject>asteatosis</subject><subject>clinical questions</subject><subject>Decision making</subject><subject>Emollients - therapeutic use</subject><subject>guidelines</subject><subject>Humans</subject><subject>Ichthyosis</subject><subject>Japan</subject><subject>Medical treatment</subject><subject>moisturizers for medical use</subject><subject>Patients</subject><subject>Pruritus</subject><subject>Pruritus - diagnosis</subject><subject>Pruritus - drug therapy</subject><subject>Pruritus - etiology</subject><subject>Skin</subject><subject>Stratum corneum</subject><subject>xerosis</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtOwzAUQC0EouUxsyFLLCwpfsV2RlTKo6rEArPlOjfFVeKUOAH170kodGDBy5Wsc4-uDkIXlExo_24oFzLRlOsJlSzjB2i8_zlEY8J1mjBB1AidxLgmhGUpJcdoxEWmiFJyjBazsCp9fMMf0ERfB1wXeNX5HEofIOKibnD7Briywa6ggtAOgI0t2LaOPmJGGMU-4Lnd2HCGjgpbRjj_mafo9X72Mn1MFs8PT9PbReIETXkCmlKhqGI5AcgZVZZI6VLgijslMkGchqUgghOmUxDOUZ1LVUhwxZI5WfBTdL3zbpr6vYPYmspHB2VpA9RdNEzSNKOaM9GjV3_Qdd01ob-up_pUmqiU9NTNjnJNHWMDhdk0vrLN1lBihtBmyGqGrOY7dL9x-ePtlhXke_63bA-kO-DTl7D9z2fmd7Od-AtaE4T7</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Saeki, Hidehisa</creator><creator>Tsunemi, Yuichiro</creator><creator>Arai, Satoru</creator><creator>Ichiyama, Susumu</creator><creator>Katoh, Norito</creator><creator>Kikuchi, Katsuko</creator><creator>Kubo, Akiharu</creator><creator>Terui, Tadashi</creator><creator>Nakahara, Takeshi</creator><creator>Futamura, Masaki</creator><creator>Murota, Hiroyuki</creator><creator>Igarashi, Atsuyuki</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1508-9514</orcidid><orcidid>https://orcid.org/0000-0002-3498-2482</orcidid><orcidid>https://orcid.org/0000-0002-5903-3187</orcidid><orcidid>https://orcid.org/0000-0003-2811-8273</orcidid><orcidid>https://orcid.org/0000-0002-1095-0355</orcidid><orcidid>https://orcid.org/0000-0002-0450-1377</orcidid><orcidid>https://orcid.org/0000-0003-3590-6489</orcidid></search><sort><creationdate>202203</creationdate><title>English version of guidelines for the management of asteatosis 2021 in Japan</title><author>Saeki, Hidehisa ; Tsunemi, Yuichiro ; Arai, Satoru ; Ichiyama, Susumu ; Katoh, Norito ; Kikuchi, Katsuko ; Kubo, Akiharu ; Terui, Tadashi ; Nakahara, Takeshi ; Futamura, Masaki ; Murota, Hiroyuki ; Igarashi, Atsuyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4153-e81147172d0eed217a066c5e373c74940c8eb40430285e4cc18d67f6ecfb2c6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>asteatosis</topic><topic>clinical questions</topic><topic>Decision making</topic><topic>Emollients - therapeutic use</topic><topic>guidelines</topic><topic>Humans</topic><topic>Ichthyosis</topic><topic>Japan</topic><topic>Medical treatment</topic><topic>moisturizers for medical use</topic><topic>Patients</topic><topic>Pruritus</topic><topic>Pruritus - diagnosis</topic><topic>Pruritus - drug therapy</topic><topic>Pruritus - etiology</topic><topic>Skin</topic><topic>Stratum corneum</topic><topic>xerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saeki, Hidehisa</creatorcontrib><creatorcontrib>Tsunemi, Yuichiro</creatorcontrib><creatorcontrib>Arai, Satoru</creatorcontrib><creatorcontrib>Ichiyama, Susumu</creatorcontrib><creatorcontrib>Katoh, Norito</creatorcontrib><creatorcontrib>Kikuchi, Katsuko</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Terui, Tadashi</creatorcontrib><creatorcontrib>Nakahara, Takeshi</creatorcontrib><creatorcontrib>Futamura, Masaki</creatorcontrib><creatorcontrib>Murota, Hiroyuki</creatorcontrib><creatorcontrib>Igarashi, Atsuyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saeki, Hidehisa</au><au>Tsunemi, Yuichiro</au><au>Arai, Satoru</au><au>Ichiyama, Susumu</au><au>Katoh, Norito</au><au>Kikuchi, Katsuko</au><au>Kubo, Akiharu</au><au>Terui, Tadashi</au><au>Nakahara, Takeshi</au><au>Futamura, Masaki</au><au>Murota, Hiroyuki</au><au>Igarashi, Atsuyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>English version of guidelines for the management of asteatosis 2021 in Japan</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2022-03</date><risdate>2022</risdate><volume>49</volume><issue>3</issue><spage>e77</spage><epage>e90</epage><pages>e77-e90</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>This is the English version of guidelines for the management of asteatosis 2021 in Japan. Asteatosis is a synonym of xerosis found in a wide range of diseases that induce dry skin through impaired functions of either water retention of the stratum corneum or skin covering with acid mantle. Patients with asteatosis may be accompanied by pruritus. Moisturizers are the first‐line treatment for asteatosis and their adequate use must be recommended. The main purpose of the present guidelines is to define skin symptoms requiring treatment with moisturizers for medical use in patients with asteatosis. If the deterioration of marked scaling or scratch marks is predicted, therapeutic intervention with moisturizers for medical use should be considered even in the absence of pruritus. Regarding six important points requiring decision‐making in clinical practice (clinical questions), we evaluated the balance between the benefits and harm of medical interventions in reference to previous reports of clinical research, and presented the recommendation grades and evidence levels to optimize the patient outcome by medical interventions.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34970776</pmid><doi>10.1111/1346-8138.16293</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1508-9514</orcidid><orcidid>https://orcid.org/0000-0002-3498-2482</orcidid><orcidid>https://orcid.org/0000-0002-5903-3187</orcidid><orcidid>https://orcid.org/0000-0003-2811-8273</orcidid><orcidid>https://orcid.org/0000-0002-1095-0355</orcidid><orcidid>https://orcid.org/0000-0002-0450-1377</orcidid><orcidid>https://orcid.org/0000-0003-3590-6489</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0385-2407 |
| ispartof | Journal of dermatology, 2022-03, Vol.49 (3), p.e77-e90 |
| issn | 0385-2407 1346-8138 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2615918324 |
| source | Wiley-Blackwell Journals; MEDLINE |
| subjects | asteatosis clinical questions Decision making Emollients - therapeutic use guidelines Humans Ichthyosis Japan Medical treatment moisturizers for medical use Patients Pruritus Pruritus - diagnosis Pruritus - drug therapy Pruritus - etiology Skin Stratum corneum xerosis |
| title | English version of guidelines for the management of asteatosis 2021 in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T20%3A07%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=English%20version%20of%20guidelines%20for%20the%20management%20of%20asteatosis%202021%20in%20Japan&rft.jtitle=Journal%20of%20dermatology&rft.au=Saeki,%20Hidehisa&rft.date=2022-03&rft.volume=49&rft.issue=3&rft.spage=e77&rft.epage=e90&rft.pages=e77-e90&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16293&rft_dat=%3Cproquest_cross%3E2615918324%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2634680750&rft_id=info:pmid/34970776&rfr_iscdi=true |